Treatment of moderate-to-severe alopecia areata in adolescents with baricitinib: A retrospective review of 29 patients

Anthony Moussa; Samantha Eisman; Ahmed Kazmi; Janina Poa; Vijaya Chitreddy; Deepani Rathnayake; Shobha Joseph; Rodney Daniel Sinclair; Bevin Bhoyrul

doi:10.1016/j.jaad.2022.12.033

Treatment of moderate-to-severe alopecia areata in adolescents with baricitinib: A retrospective review of 29 patients

J Am Acad Dermatol. 2023 May;88(5):1194-1196. doi: 10.1016/j.jaad.2022.12.033. Epub 2023 Jan 7.

Authors

Anthony Moussa¹, Samantha Eisman², Ahmed Kazmi², Janina Poa², Vijaya Chitreddy², Deepani Rathnayake², Shobha Joseph², Rodney Daniel Sinclair³, Bevin Bhoyrul²

Affiliations

¹ Sinclair Dermatology, East Melbourne, Victoria, Australia. Electronic address: [email protected].
² Sinclair Dermatology, East Melbourne, Victoria, Australia.
³ Sinclair Dermatology, East Melbourne, Victoria, Australia; University of Melbourne, Melbourne, Victoria, Australia.

PMID: 36623557
DOI: 10.1016/j.jaad.2022.12.033

No abstract available

Keywords: Janus kinase inhibitor; adolescents; alopecia areata; alopecia totalis; alopecia universalis; autoimmune; autoimmune hair loss; baricitinib; combination therapy; hair follicle; immune privilege; minoxidil; ruxolitinib; therapy; tofacitinib.

MeSH terms

Adolescent
Alopecia / therapy
Alopecia Areata* / drug therapy
Humans
Pyrazoles / therapeutic use
Retrospective Studies

Substances

baricitinib
Pyrazoles

Supplementary concepts

Diffuse alopecia